Director – MedTechnique Consulting

B.App.Sc (Physio), GradDIp Health Ec & Policy

Sarah Griffin is the founder of MedTechnique Consulting and has more than 25 years of experience in the medical technology sector including health economics, health insurance, health policy and legislation, medical finance, reimbursement systems and government relations. Sarah’s strengths lie in her strategic approach to market access and the creation of effective reimbursement and health economic strategies. She is listed on the Federal Register of Lobbyists and is an expert in preparing complex reimbursement submissions. Since founding MedTechnique Consulting in 2013, she has assisted numerous medical technology companies gain market access for innovative technologies.

She has filled senior and international roles with St Jude Medical, MBF and Mercy Health Services in the United States. Sarah received her B.App Sc (Physio) from the University of Sydney and a GradDip in Health Economics and Policy from Monash University. She has served on several committees of the Medical Technology Association (MTAA) and the Trade and Government Committee of the American Chamber of Commerce. She is a current chair of the committee member of MTAA. She is current chair of the AusMedtech Health Economics Expert Panel and has been appointed by the Australian Government to the Industry Working Group for Prostheses Benefit Reform

Sarah is an experienced speaker and facilitator for industry conferences and corporate events both in Australia and worldwide. She is also experienced in facilitating panels and discussions as part of an event. If you are looking for an experienced health economist with a firm grasp of Australian Health policy for your next event contact us to start the discussion.

Consultant Health Economist

BSc(Hons), GradDipEpi, MAICD

George has more than 25 years of experience in the medical technology and pharmaceutical industries including clinical research, health economics, reimbursement, pricing and business development. He has worked at both local and international levels at senior levels in Australia, Belgium and the United States including Pharmacia, Johnson & Johnson, Schering-Plough and Merck. George established Emerald Corporate Group and has since assisted multiple healthcare companies to successfully gain market access for innovative technologies.

George is expert in developing health economic and reimbursement strategies, strategic pricing initiatives, early assessment of commercial opportunities and preparation of health economic submissions to reimbursement authorities.

George received his BSc[Hons] from the University of Sydney and Grad Dip Epi (Pharmacoepi) from the University of Newcastle. He is a current member of ISPOR and the current Treasurer of ISPOR Australia. He is an active member of ARCS(Australasian Society of Regulatory and Clinical Scientists), HTAi (Health Technology Assessment International), iHEA(Internatiional Health Economics Association) and a member of the AICD(Australian Institute of Company Directors).

Health Economist

BA, BNurse GradDipEcon, MHEcon

Jodie has over 20 years of experience in the health care industry. She has degrees in Nursing, Economics and a Masters in Health Economics.  Her background includes Nursing, Qld Health Project Management, retrospective clinical studies, systematic literature reviews and most extensively, Health Economics and Outcomes Research in the Pharmaceutical and Medical Device industry. Jodie specializes in translating medical terminology into effective health care communication for the consumer.

Jodie has worked as an RN in Surgical/Thoracic and Radiation Oncology and has worked in Project Management for Qld Health, auditing and modeling the costs of pressure ulcer prevention in Queensland public hospitals. Jodie was employed by the Australian Centre for Research on Health Economics (ACERH) where she undertook a cost analysis of major trauma in Queensland. 

More recently she worked as a Senior Health Economics Analyst at IQVIA in London where Jodie was involved in cost-effectiveness model population, building and design and communication of these results in reports, presentations and manuscripts.  She also worked in value communication including the development of multi-country core value dossiers and core reimbursement dossiers, environmental analysis packages, drug reimbursement submissions to the Australian PBAC, the UK NICE (England), SMC (Scotland) and AWMSG (Wales), Poland and the Netherlands.

Jodie now works as a consultant in medical writing and health economics, undertaking literature reviews, data extraction, value dossier chapter writing and MSAC submission writing.